苗慧, 施林心, 白海生, 邵卫仙, 袁成, 刘亚洲, 孙苏平, 陈宏林, 罗举建, 惠华, 张文. 宫颈癌不同体位调强放疗对周围正常组织的辐射剂量学研究[J]. 中国辐射卫生, 2018, 27(4): 381-384.
MIAO Hui, SHI Linxin, BAI Haisheng, SHAO Weixian, YUAN Cheng, LIU Yazhou, SUN Suping, CHEN Honglin, LUO Jujian, HUI Hua, ZHANG Wen. Dosimetric study on intensity-modulated radiotherapy with dissimilar position on peripheral normal tissues and organs of cervical cancer. , 2018, 27(4): 381-384.
[1] Lyman JT.Complication probability as assessed from dose volume histograms[J].Rad Res,1985,104:S13-S19. [2] Allemani C,Weir HK,Carreira H,et al.Global surveillance of cancer survival 1995-2009:analysis of individual data for 25676887 patients from 279 population-based registries in 67 countries(CONCORD-2)[J].Lancet,2015,385(9972):977-1010. [3] 王静,许可葵,史百高,等.4374例宫颈癌患者预后及其影响因素分析[J].中国肿瘤,2014,23(4):281-288. [4] Wang W,Meng Q,Hou X,et al.Efficacy and toxicity of image-guided intensity-modulated radiation therapy combined with dose-escalated brachytherapy for stage ⅡB cervical cancer[J].Oncotarget, 2017,8(61):102965-102973. [5] Vandecasteele K,Makar A,Van den Broecke R,et al.Intensity-modulated arc therapy with cisplatin as neo-adjuvant treatment for primary irresectable cervical cancer.Toxicity,tumour response and outcome[J].Strahlenther Onkol, 2012,188(7):576-581. [6] Du XX,Yang H,Zhang HJ,et al.Clinical study of intensity modulated radiotherapy and three-dimensional conformal radiotherapy with three-dimensional brachytherapy and concurrent chemotherapy for patients with advanced cervical cancer[J].Zhonghua Fu Chan Ke Za Zhi,2017,52(10):679-686. [7] DU XL,Tao J,Sheng XG,et al.Intensity-modulated radiation therapy for advanced cervical cancer:a comparison of dosimetric and clinical outcomes with conventional radiotherapy[J].Gynecol Oncol,2012,125(1):151-157. [8] Igdem S,Ercan T,Alco G,etal.Dosimetric comparison of intensity modulated pelvic radiotherapy with 3D conformal radiotherapy in patients with gynecologic malignancies[J].Eur J Gynaecol Oncol,2009,30(5):547-551. [9] 庞皓文,邱杰,孙帅,等.宫颈癌调强放疗中直肠体积与位置变化及对吸收剂量影响[J].中华放射肿瘤学杂志,2012,21(3):258-261. [10] Olofsen-van Acht M,van den Berg H,Quint S,et al.Reduction of Irradiated Small Bowel Volume and Accurate Patient Positioning by Use of A Bellyboard Device in Pelvic Radiotherapy of Gynecological Cancer Patients[J].Radiother Oncol,2001,59(1):87-93. [11] Adli M,Mayr NA,Kaiser HS,et al.Does prone positioning reduce small bowel dose in pelvic radiation with intensity modulated radiotherapy for gynecologic cancer[J].Int J Radiat Oncol Biol Phys,2003,57:230-238. [12] 邢晓汾,郑亚琴,臧志芳,等.子宫颈癌调强放射治疗中不同体位的计量学研究[J].肿瘤研究与临床,2010,22(2):115-117. [13] 韩丽萍,孙晓慧,李元,等.宫颈鳞癌组织中PD-1和PD-L1的表达及其临床意义[J].中国妇幼保健,2016,(20):4290-4293. [14] Lin Y,Zhai E,Liao B,et al.Autocrine VEGF signaling Promotes cell proliferation through a PLC-dependent pathway and modulates Apatinib treatment efficacy in gastric cancer[J].Oncotarget,2017,8(7):11990-12002. [15] Zhang L,Chen Q,Hu J,et al.Expression of HIF-2α and VEGF in cervical squamous cell carcinoma and its clinical significance[J].Biomed Res Int,2016(2016):5631935-5631942. [16] 刘伟,张建文.阿帕替尼对宫颈癌Hela细胞体外放射作用的研究[J].中国药业,2017,26(19):27-30.